Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-24 @ 10:34 PM
Ignite Modification Date:
2025-12-24 @ 10:34 PM
NCT ID:
NCT07048535
Eligibility Criteria:
Inclusion Criteria:
* ≤ 26-years old at the time of the first CAR treatment
* Receipt of a CD19-containing CAR T-cell product (investigational or commercial) for B- ALL
* Receipt of one unique CAR product (reinfusion of same product allowed)
* Sustained remission without subsequent therapy post-CAR (exception= post-CAR consolidative HCT)
* Receipt of only one prior HCT (inclusive of pre- or post-CAR)
* ≥ 2-years post last CAR T-cell infusion
Exclusion Criteria:
* Inability or unwillingness of research participant or legal guardian/representative to give written informed consent
Healthy Volunteers:
False
Sex:
ALL
Study:
NCT07048535
Study Brief:
Protocol Section:
NCT07048535